Cargando…
An identical novel mutation in BRCA1 and a common haplotype in familial ovarian cancer in non-Ashkenazi Jews.
Unique germline mutations in BRCA1 and BRCA2 account for inherited predisposition to breast and ovarian cancer in high-risk families. In Jewish high-risk individuals of Ashkenazi (east European) descent, three predominant mutations, 185delAG and 5382insC (BRCA1) and 6174delT (BRCA2), seem to account...
Autores principales: | Theodor, L., Bar-Sade, R., Kruglikova, A., Ben-Baruch, G., Risel, S., Shiri-Sverdlov, R., Hirsh Yechezkel, G., Modan, B., Papa, M. Z., Rechavi, G., Friedman, E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150352/ https://www.ncbi.nlm.nih.gov/pubmed/9667663 |
Ejemplares similares
-
Population‐based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants
por: Castillo, Cecilia, et al.
Publicado: (2022) -
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping
por: Olshen, Adam B, et al.
Publicado: (2008) -
The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews
por: Shiner, Tamara, et al.
Publicado: (2021) -
Genetic contribution to multiple sclerosis risk among Ashkenazi Jews
por: Khankhanian, Pouya, et al.
Publicado: (2015) -
Randomised trial of population‐based
BRCA
testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes
por: Burnell, Matthew, et al.
Publicado: (2022)